You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 10, 2024

Claims for Patent: 8,765,927

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 8,765,927

Title:	Identification of isolated genomic nucleotide fragments from the p15 region of chromosome 11 encoding human cluster of differentiation antigen 81 and variants thereof
Abstract:	Provided herein are isolated genomic polynucleotide fragments from the p15 arm of chromosome 11 and methods of use.
Inventor(s):	Ryan; James (Augusta, GA)
Assignee:
Application Number:	13/845,430
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,765,927
Patent Claims:	1. A method of identifying variants of SEQ ID NO:11 or its complementary sequence comprising (a) isolating genomic polynucleotide from a subject and (b) determining the presence or absence of a variant in said genomic DNA using a polynucleotide consisting of a 5'-noncoding, 3'-non coding or intron fragment of SEQ ID NO: 11 or its complementary sequence, wherein said 5'-noncoding, 3'-noncoding or intron fragment or its complementary sequence is at least 20 nucleotides in length and wherein said 5'-noncoding region consists of nucleotides 1-10235 of SEQ ID NO:11, and said 3'-noncoding region consists of nucleotides 30341-37113 of SEQ ID NO: 11. 2. The method according to claim 1, wherein said genomic polynucleotide is a DNA or RNA. 3. A method for detecting the presence or absence of a nucleic acid sequence of SEQ ID NO:11 or its complementary sequence in a sample, said method comprising contacting the sample with a polynucleotide consisting of a 5-'noncoding, 3'-noncoding or intron fragment of SEQ ID NO:11 or its complementary sequence, wherein said 5'-noncoding, 3'-noncoding or intron fragment or its complementary sequence is at least 20 nucleotides in length and wherein said 5'-noncoding region consists of nucleotides 1-10235 of SEQ ID NO:11, and said 3'-noncoding region consists of nucleotides 30341-37113 of SEQ ID NO:11. 4. The method according to claim 3, wherein said polynucleotide is a DNA or RNA.

Details for Patent 8,765,927

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986	⤷ Try a Trial	2020-10-31
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132		⤷ Try a Trial	2020-10-31
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132		⤷ Try a Trial	2020-10-31
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.